Geir Bukholm, who heads the vaccine work at the National Institute of Public Health, informs Aftenposten that the vaccines will have different effects. Some will work so that vulnerable patients do not become so seriously ill that they need a respirator or die, while some will also have a significant effect by reducing infection.
– When we finally recommend who should get the vaccine first, it is on the basis of ethics and knowledge of the vaccine’s properties, Bukholm tells the newspaper.
An ethics committee has been set up to present proposals on values and ethical principles for prioritization. This will happen well before a vaccine is available in Norway.
Bukholm says that the task of making recommendations also includes assessing those who are particularly vulnerable to infection, and those who have critical societal functions.
It is already known that the corona vaccine will be free in Norway.